Author

Sai P. Thankamony

Observed names: S. Thankamony, Sai P Thankamony, Sai Thankamony

Observed institutions: Rush University Medical Center, Biogen (United States), Harvard University, Bristol-Myers Squibb (United States), Fulcrum Therapeutics (United States)

OpenAlex ID: A5034350503

Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models

2018 · Alex McCampbell, Tracy Cole, et al. · Journal of Clinical Investigation · 287

C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity

2018 · Bhuvaneish T. Selvaraj, Matthew R. Livesey, et al. · Nature Communications · 214

Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis

2006 · Sai P. Thankamony, Warren Knudson · Journal of Biological Chemistry · 120

Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells

2011 · Sai P. Thankamony, Robert Sackstein · Proceedings of the National Academy of Sciences · 101

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

2019 · Steven Piccoli, Devangi Mehta, et al. · Bioanalysis · 100

Induction of CD44 cleavage in articular chondrocytes

2010 · Nobunori Takahashi, Cheryl B. Knudson, et al. · Arthritis & Rheumatism · 45

Exploratory Biomarker Assays: Key Assay Parameters to Evaluate in the Face of Evolving Biomarker Context-of-Use

2019 · Sai P Thankamony, Yan Zhang · Bioanalysis · 4

Apg777, Anti-il-13 Monoclonal Antibody, Demonstrates Extended Half-life and Sustained Inhibition of Type 2 Inflammatory Biomarkers

2024 · X. Lim, E. Winter, et al. · Annals of Allergy Asthma & Immunology · 3

Calibrator Material Selection: A Key Criteria During Biomarker Assay Method Development

2021 · Sai P Thankamony, Rong Liu, et al. · Bioanalysis · 3

Late Breaking Abstract - A single dose of zumilokibart (APG777) durably suppresses FeNO through 32 weeks in patients with mild-to-moderate asthma

2026 · Mario Castro, Jeremy Cole, et al. · European Respiratory Journal

Apg808, a Novel Anti-il-4ra Antibody With Half-life Extension Technology: Safety, Pharmacokinetics, and Pharmacodynamics

2025 · A. Kamboj, C. Hale, et al. · Annals of Allergy Asthma & Immunology

264 APG777, a half-life-extended mAb targeting IL-13, demonstrates rapid and sustained inhibition of serum TARC levels in patients with moderate to severe atopic dermatitis

2025 · Emma Guttman-Yassky, Sai Thankamony, et al. · Journal of Investigative Dermatology

APG808, an anti-IL-4Rα monoclonal antibody, demonstrates safety, extended half-life, and sustained inhibition of type 2 inflammatory biomarkers

2025 · Amol Kamboj, Erica Winter, et al. · European Respiratory Journal

Late Breaking Abstract - Sustained suppression of type 2 inflammatory biomarkers in asthma with APG808, a half-life extended anti-IL-4Rα monoclonal antibody

2025 · Amol Kamboj, Lauren Wood, et al. · European Respiratory Journal

711 - Prolonged half-life and sustained inhibition of key inflammatory biomarkers: a phase 1 study of APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13

2024 · Xiu Qin Lim, Erica Winter, et al. · British Journal of Dermatology

LB945 Prolonged half-life and sustained inhibition of key inflammatory biomarkers: a phase 1 study of APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13

2024 · X.Q. Lim, E. Winter, et al. · Journal of Investigative Dermatology

Works count: 16

Citation count: 877

H-index: 6

I10-index: 6